Asia Fact Check Lab: Is Paxlovid too expensive for China to purchase?
In Brief
China’s National Healthcare Security Administration recently broke off talks with Pfizer to include Paxlovid among the medications eligible for reimbursement under the country’s national health insurance system. Officials said the company was …